{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:07:59Z","timestamp":1788829679238,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019125","name":"National Institute of Pharmaceutical Education and Research, Ahmedabad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019125","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.talanta.2026.130216","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:51:57Z","timestamp":1782345117000},"page":"130216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Integrated analytical characterization and multiscale modeling of supramolecular interactions in lumefantrine-curcumin coamorphous systems with enhanced biopharmaceutical and anticancer performance"],"prefix":"10.1016","volume":"311","author":[{"given":"Rahul","family":"Khemchandani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekta","family":"Pardhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansari Muhammad","family":"Faizan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandraiah","family":"Godugu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelesh Kumar","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gananadhamu","family":"Samanthula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.talanta.2026.130216_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.137756","article-title":"Improving dissolution rate and solubility of palbociclib salts\/cocrystal for anticancer efficacy","volume":"1305","author":"Allu","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.talanta.2026.130216_bib2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.molstruc.2019.05.054","article-title":"Cocrystallization of carbamazepine with amides: cocrystal and eutectic phases with improved dissolution","volume":"1193","author":"Sathisaran","year":"2019","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.talanta.2026.130216_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126283","article-title":"Integrated experimental, computational and machine learning approaches for the development of Apremilast-Aceclofenac coamorphous systems","volume":"686","author":"Khemchandani","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.talanta.2026.130216_bib4","article-title":"Enhanced bioavailability and therapeutic efficacy of Ibrutinib and naringenin-loaded self-nanoemulsifying drug delivery system","volume":"109","author":"Jati","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"8","key":"10.1016\/j.talanta.2026.130216_bib5","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1080\/07391102.2024.2308048","article-title":"Monophasic coamorphous sulpiride: a leap in physicochemical attributes and dual inhibition of GlyT1 and P-glycoprotein, supported by experimental and computational insights","volume":"43","author":"Pardhi","year":"2025","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.talanta.2026.130216_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.137045","article-title":"Design, development and characterization of the Apremilast and Indomethacin coamorphous system","volume":"1299","author":"Pardhi","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"11","key":"10.1016\/j.talanta.2026.130216_bib7","doi-asserted-by":"crossref","first-page":"10112","DOI":"10.1021\/acsabm.5c01473","article-title":"Strategic nanosuspension of darolutamide for enhanced dissolution, bioavailability, and potentiated prostate cancer treatment: insights from multiscale computational modeling","volume":"8","author":"Pardhi","year":"2025","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.talanta.2026.130216_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.125056","article-title":"Multi-method coamorphous systems of lumefantrine with alpha ketoglutaric acid: comprehensive characterization, biological evaluation and stability analysis","volume":"669","author":"Khemchandani","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.talanta.2026.130216_bib9","series-title":"Nanocrystal Technologies in Biomedical Sciences: Advances in Crystal Development, Characterization and Targeted Drug Delivery","first-page":"207","article-title":"Recent breakthroughs in nanocrystal development","author":"Pardhi","year":"2026"},{"key":"10.1016\/j.talanta.2026.130216_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.142014","article-title":"Molecular dynamics and interactions in amorphous solid dispersion of Erlotinib HCl for improved cancer therapy","volume":"1336","author":"Hussan","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.talanta.2026.130216_bib11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.molstruc.2017.04.015","article-title":"Solid dispersions of Myricetin with enhanced solubility: formulation, characterization and crystal structure of stability-impeding Myricetin monohydrate crystals","volume":"1141","author":"Mure\u015fan-Pop","year":"2017","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.talanta.2026.130216_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2025.127225","article-title":"Enhancing solubility, bioavailability and anti-cancer efficacy of aprepitant through a naringin-based co-amorphous system","volume":"425","author":"Pardhi","year":"2025","journal-title":"J. Mol. Liq."},{"issue":"1","key":"10.1016\/j.talanta.2026.130216_bib13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1021\/acs.molpharmaceut.5c00513","article-title":"Drug\u2013drug coamorphous system of Tadalafil and finasteride for enhanced pharmaceutical performance","volume":"23","author":"Bhale","year":"2026","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.talanta.2026.130216_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.130709","article-title":"Structure and energetics of intermolecular association in two lurasidone co-amorphous drug systems","volume":"1242","author":"Silva","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.talanta.2026.130216_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.143694","article-title":"Intermolecular interactions in melt-quenched co-amorphous acetaminophen-ascorbic Acid-PVP K30: FTIR, XRD, and DFT analysis","volume":"1349","author":"Ibrahim","year":"2026","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.talanta.2026.130216_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134373","article-title":"Molecular modeling and in vitro studies to assess solubility enhancement of nevirapine by solid dispersion technique","volume":"1273","author":"Rao","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.talanta.2026.130216_bib17","article-title":"Novel drug-drug co-amorphous systems of olaparib with nonsteroidal anti-inflammatory drugs with improved solubility, physical stability, antitumor activity and pharmacokinetics","volume":"101","author":"Luo","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"2","key":"10.1016\/j.talanta.2026.130216_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103883","article-title":"Drug\u2013drug co-amorphous systems: an emerging formulation strategy for poorly water-soluble drugs","volume":"29","author":"Wang","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.talanta.2026.130216_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.lwt.2022.114091","article-title":"Co-amorphous delivery systems based on curcumin and hydroxycinnamic acids: stabilization, solubilization, and controlled release","volume":"170","author":"Feng","year":"2022","journal-title":"LWT"},{"issue":"1","key":"10.1016\/j.talanta.2026.130216_bib20","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1080\/10717544.2022.2048132","article-title":"Construction of pH-sensitive targeted micelle system co-delivery with curcumin and dasatinib and evaluation of anti-liver cancer","volume":"29","author":"Zeng","year":"2022","journal-title":"Drug Deliv."},{"issue":"15","key":"10.1016\/j.talanta.2026.130216_bib21","doi-asserted-by":"crossref","first-page":"15400","DOI":"10.1021\/acsomega.5c00008","article-title":"Inhalable TPGS\/DPPC micelles coloaded with curcumin and icariin for targeted lung cancer therapy","volume":"10","author":"Jiang","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.talanta.2026.130216_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202501930","article-title":"Phytoconstituents of Gmelina Arborea as potential breast cancer inhibitors: LC\u2010MS\/MS, docking, MD simulations, and in vitro evaluation","volume":"23","author":"Harini","year":"2026","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.talanta.2026.130216_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.145134","article-title":"Artesunate exhibits synergistic anti-cancer effects with cisplatin on lung cancer A549 cells by inhibiting MAPK pathway","volume":"766","author":"Li","year":"2021","journal-title":"Gene"},{"key":"10.1016\/j.talanta.2026.130216_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.141375","article-title":"In silico characterization of indole-substituted densely functionalized pyrrole against breast cancer: integrating DFT, molecular docking, MD simulations, and ADME analysis","volume":"1328","author":"Mouli","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.talanta.2026.130216_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115517","article-title":"Structural characterization and in silico toxicity prediction of degradation impurities of roxadustat","volume":"234","author":"Mahajan","year":"2023","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2026.130216_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.115077","article-title":"Structural characterization of novel hydrolytic and oxidative degradation products of acalabrutinib by LC-Q-TOF-MS, H\/D exchange and NMR","volume":"221","author":"Kushwah","year":"2022","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2026.130216_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2025.214542","article-title":"PEGylated liposomes co-encapsulating darolutamide and hesperetin for enhanced prostate cancer therapy: 2D, 3D PC3 models and in-vivo evaluation","volume":"180","author":"Patil","year":"2026","journal-title":"Biomater. Adv."},{"issue":"3","key":"10.1016\/j.talanta.2026.130216_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.10167","article-title":"Identification and structural characterization of degradation products of tivozanib using LC-Q-TOF-MS\/MS and NMR: an in silico approach for degradation and toxicity prediction","volume":"40","author":"Shaikh","year":"2026","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"21","key":"10.1016\/j.talanta.2026.130216_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202404945","article-title":"An unusual, methylated impurity in Diethyl sulphate: identification, structure elucidation, and linkage with N-Methyl impurity of an active pharmaceutical ingredient","volume":"10","author":"Bhale","year":"2025","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.talanta.2026.130216_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2026.117492","article-title":"Characterization of forced degradation products of tyrosine kinase inhibitor apatinib mesylate by LC-MS\/MS and NMR with in silico toxicity assessment","volume":"277","author":"Shaikh","year":"2026","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2026.130216_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.152472","article-title":"Exploring the anticancer potential of novel benzimidazolium salts: synthesis, biological evaluation, DFT perspective, and docking simulation for inhibition of VEGFR2","volume":"780","author":"Kundu","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.talanta.2026.130216_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-19370-7","article-title":"Bioactivity of crude fucoidan extracted from Sargassum ilicifolium (Turner) C. Agardh","volume":"12","author":"Tsou","year":"2022","journal-title":"Sci. Rep."},{"issue":"30","key":"10.1016\/j.talanta.2026.130216_bib33","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1080\/17435889.2024.2405455","article-title":"Niosomal gel improves dermal delivery of nimbolide: a promising approach for treatment of psoriasis","volume":"19","author":"Thatikonda","year":"2024","journal-title":"Nanomedicine"},{"issue":"10","key":"10.1016\/j.talanta.2026.130216_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2025.103958","article-title":"Understanding the degradation behaviour of masitinib by stress testing, UHPLC, HRMS, NMR, APCI-MS, DFT and prediction of toxicity using in silico tools","volume":"114","author":"Dhiman","year":"2025","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.talanta.2026.130216_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122707","article-title":"Tranilast-matrine co-amorphous system: strong intermolecular interactions, improved solubility, and physiochemical stability","volume":"635","author":"Hu","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.talanta.2026.130216_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2020.113860","article-title":"Adsorption behaviour of chronic blistering agents on graphdiyne; excellent correlation among SAPT, reduced density gradient (RDG) and QTAIM analyses","volume":"316","author":"Khan","year":"2020","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.talanta.2026.130216_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2023.121524","article-title":"H \u2013 bond interactions in water multimers and water multimers \u2013 pyridine complexes: natural bond orbital and reduced density gradient isosurface analyses","volume":"377","author":"Sangeetha","year":"2023","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.talanta.2026.130216_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2025.114972","article-title":"Sulfasalazine\u2013quercetin co-amorphous systems: sustained release behaviours and enhanced pharmacokinetics","volume":"220","author":"Deng","year":"2026","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"6","key":"10.1016\/j.talanta.2026.130216_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2026.104239","article-title":"Stabilization of supersaturation for enhanced oral absorption of a BCS II drug efonidipine hydrochloride: eudragit\u00ae L100-55-based amorphous solid dispersions","volume":"115","author":"Huang","year":"2026","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.talanta.2026.130216_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2026.115099","article-title":"Mechanistic enhancement of oral bioavailability through a coamorphous apremilast-aceclofenac systems: integrated LC-MS\/MS Bioanalysis, in vivo pharmacokinetics, and PBPK modeling","volume":"225","author":"Khemchandani","year":"2026","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.talanta.2026.130216_bib41","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.3390\/pharmaceutics13122137","article-title":"Drug delivery strategies for curcumin and other natural Nrf2 modulators of oxidative stress-related diseases","volume":"13","author":"Grilc","year":"2021","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.talanta.2026.130216_bib42","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1021\/acsabm.5c02537","article-title":"In vitro and in vivo assessment of darolutamide encapsulated lipid-extruded PEGylated liposomal formulation","volume":"9","author":"Pardhi","year":"2026","journal-title":"ACS Appl. Bio Mater."},{"issue":"3","key":"10.1016\/j.talanta.2026.130216_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e25172","article-title":"d-\u03b1-Tocopheryl polyethylene glycol 1000 succinate surface scaffold polysarcosine based polymeric nanoparticles of enzalutamide for the treatment of colorectal cancer: in vitro, in vivo characterizations","volume":"10","author":"Shah","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.talanta.2026.130216_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121657","article-title":"Development and characterization of a spray-dried inhalable ciprofloxacin-quercetin co-amorphous system","volume":"618","author":"Alhajj","year":"2022","journal-title":"Int. J. Pharm."}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914026008726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914026008726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:30:10Z","timestamp":1788827410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039914026008726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":44,"alternative-id":["S0039914026008726"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2026.130216","relation":{},"ISSN":["0039-9140"],"issn-type":[{"value":"0039-9140","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated analytical characterization and multiscale modeling of supramolecular interactions in lumefantrine-curcumin coamorphous systems with enhanced biopharmaceutical and anticancer performance","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2026.130216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130216"}}